...
首页> 外文期刊>Oncogene >Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition
【24h】

Id-1 activates Akt-mediated Wnt signaling and p27Kip1 phosphorylation through PTEN inhibition

机译:ID-1通过PTEN抑制激活AKT介导的WNT信号传导和P27KIP1磷酸化

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Inhibitor of differentiation-1 (Id-1) has been accepted as a putative oncogene to promote oncogenic processes through inactivation of tumor suppressors and activation of growth promoting pathways. Here, we show that Id-1 activates the Akt pathway by inhibition of phosphatase and tensin homologue deleted on chromosome 10 (PTEN) transcription through downregulation of p53. Id-1 negatively regulated both p53 and PTEN at the transcriptional level. In promoter assay with serial deletion and chromatin immunoprecipitation assay, the binding of p53 to the PTEN promoter was reduced by Id-1, suggesting that Id-1 regulates PTEN transcription through its p53 modulation. This led to Akt phosphorylation at Ser473 and the activation of the Akt-mediated canonical Wnt signaling pathway. The glycogen synthase kinase-3β phosphorylation at Ser9, stabilization and nuclear localization of β-catenin, T-cell factor (TCF)/lymphoid enhancer factor transactivation activity and cyclin D1 expression were enhanced by Id-1. On the other hand, Akt-mediated p27Kip1 phosphorylation at Thr157 and its cytosolic localization were also increased in Id-1 overexpressing MCF7 cells. In conclusion, our results disclose Id-1 as a novel PTEN inhibitor that could activate the Akt pathway and its downstream effectors, the Wnt/TCF pathway and p27Kip1 phosphorylation and suggest that the oncogenic function of Id-1 may be partly attributed to its PTEN inhibition in human breast carcinogenesis.
机译:分化-1(ID-1)的抑制剂已被认为是推定的癌基因,以通过肿瘤抑制剂的灭活和生长促进途径的活化来促进致癌过程。这里,我们表明ID-1通过抑制磷酸酶和染色体10(PTEN)转录的缺失的磷酸酶和染色素同源物通过P53的下调来激活AKT途径。 ID-1在转录水平下对P53和PTEN进行负调节。在具有连续缺失和染色质免疫沉淀测定的启动子测定中,通过ID-1降低P53与PTEN启动子的结合,表明ID-1通过其P53调节调节PTEN转录。这导致SER473的AKT磷酸化和AKT介导的规范WNT信号通路的激活。通过ID-1增强了SER9,β-连环蛋白,T细胞因子(TCF)/淋巴增强剂因子转移活性和细胞周期蛋白D1表达的Ser9,稳定和核定位时的糖原合酶激酶-3β磷酸化。另一方面,在ID-1过表达MCF7细胞中也增加了AKT介导的P27KIP1磷酸化及其细胞溶质定位。总之,我们的结果将ID-1公开为新型PTEN抑制剂,其可激活AKT途径及其下游效应器,WNT / TCF途径和P27KIP1磷酸化,并表明ID-1的致癌功能可能部分地归因于其PTEN抑制人乳腺癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号